C

Curis

D
CRIS
USD
-0.03
(-0.6803%)
Market Closed
3,247.00
Volume
-8.09
EPS
-
Div Yield
-0.536108
P/E
26,187,779.10
Market Cap
Today
4.2857%
1 Week
2.336%
1 Month
-14.118%
6 Months
-73.129%
12 Months
-18.131%
Year To Date
-65.754%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
S
SGMO
0.33
(13.3603%)
USD
C
CRSP
1.15
(2.2656%)
USD
E
EDIT
-0.11
(-3.3537%)
USD
N
NTLA
-0.05
(-0.3113%)
USD
B
BNTC
0.545
(5.2228%)
USD
REGN
REGN
8.505
(1.0417%)
USD
B
BLUE
-0.0615
(-14.0764%)
USD
GILD
GILD
6.36
(6.9463%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD

Title:
Curis

Sector:
Healthcare
Industry:
Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Do you need help or have a question?
Contact Us